PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma
Clinical trial NCT03701022 · UNKNOWN
Trial details
- NCT number
- NCT03701022
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-20
- Primary completion
- 2020-03-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.